MXPA04005104A - Regimen de dosificacion y composicion farmaceutica para anticoncepcion de emergencia. - Google Patents

Regimen de dosificacion y composicion farmaceutica para anticoncepcion de emergencia.

Info

Publication number
MXPA04005104A
MXPA04005104A MXPA04005104A MXPA04005104A MXPA04005104A MX PA04005104 A MXPA04005104 A MX PA04005104A MX PA04005104 A MXPA04005104 A MX PA04005104A MX PA04005104 A MXPA04005104 A MX PA04005104A MX PA04005104 A MXPA04005104 A MX PA04005104A
Authority
MX
Mexico
Prior art keywords
emergency contraception
pharmaceutical compositions
dosage regimen
levonorgestrel
active ingredient
Prior art date
Application number
MXPA04005104A
Other languages
English (en)
Inventor
Szabo Zsolt
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of MXPA04005104A publication Critical patent/MXPA04005104A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La invencion se refiere a un regimen de dosificacion para anticoncepcion de emergencia, a composiciones farmaceuticas para el mismo objetivo, al uso de levonorgestrel para la produccion de composiciones farmaceuticas para el mismo objetivo, y al proceso de produccion de dichas composiciones farmaceuticas. De acuerdo con la invencion, la anticoncepcion de emergencia llevada a cabo mediante el uso de levonorgestrel como principio activo se caracteriza por la administracion de una dosis unica que contiene 1.5 ?? 0.2 mg de levonorgestrel como principio activo hasta 72 horas despues del coito. Las composiciones farmaceuticas para anticoncepcion de emergencia de acuerdo con la invencion contienen unicamente 1.5 ?? 0.2 mg de levonorgestrel con excipientes conocidos, diluyentes, saborizantes o aromatizantes, estabilizadores, asi como aditivos promotores o facilitadotes de formulacion utilizados normalmente en la practica farmaceutica.
MXPA04005104A 2001-11-27 2002-11-26 Regimen de dosificacion y composicion farmaceutica para anticoncepcion de emergencia. MXPA04005104A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (1)

Publication Number Publication Date
MXPA04005104A true MXPA04005104A (es) 2004-08-19

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005104A MXPA04005104A (es) 2001-11-27 2002-11-26 Regimen de dosificacion y composicion farmaceutica para anticoncepcion de emergencia.

Country Status (33)

Country Link
US (1) US20050288264A2 (es)
EP (1) EP1448207B1 (es)
JP (1) JP2005516904A (es)
KR (1) KR100908161B1 (es)
CN (1) CN1551774A (es)
AP (1) AP1849A (es)
AT (1) ATE293978T1 (es)
AU (1) AU2002347401A1 (es)
BR (1) BR0210595A (es)
CA (1) CA2450359C (es)
DE (1) DE60203929T2 (es)
DK (1) DK1448207T3 (es)
EA (1) EA006545B1 (es)
EC (1) ECSP045171A (es)
ES (1) ES2239727T3 (es)
GE (1) GEP20063882B (es)
HR (1) HRP20040584B1 (es)
HU (1) HU227198B1 (es)
IL (1) IL159394A0 (es)
IS (1) IS2691B (es)
MA (1) MA27076A1 (es)
MX (1) MXPA04005104A (es)
NO (1) NO333984B1 (es)
NZ (1) NZ530056A (es)
OA (1) OA12730A (es)
PL (1) PL206010B1 (es)
PT (1) PT1448207E (es)
RS (1) RS50768B (es)
SI (1) SI1448207T1 (es)
TN (1) TNSN04048A1 (es)
UA (1) UA79942C2 (es)
WO (1) WO2003045397A1 (es)
ZA (1) ZA200404114B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009006823A (es) * 2006-12-20 2009-07-03 Duramed Pharmaceuticals Inc Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas.
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US9180131B2 (en) 2008-12-12 2015-11-10 Laboratoire Hra Pharma Method for contraception
PL2419108T3 (pl) 2009-04-14 2017-08-31 Laboratoire Hra Pharma Sposób antykoncepcji na żądanie
SG177284A1 (en) * 2009-06-23 2012-02-28 Bayer Pharma AG Pharmaceutical composition for emergency contraception
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
EP2714710B1 (en) 2011-06-01 2016-04-06 Estetra S.P.R.L. Process for the production of estetrol intermediates
ES2600703T3 (es) 2011-06-01 2017-02-10 Estetra S.P.R.L. Proceso para la producción de intermediarios de estetrol
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US9579329B2 (en) * 2011-08-11 2017-02-28 Estetra S.P.R.L. Use of estetrol as emergency contraceptive
KR20150085512A (ko) 2012-11-22 2015-07-23 바이엘 파마 악티엔게젤샤프트 필요시 피임을 위한 레보노르게스트렐 및 cox 억제제 함유 제약 조성물의 용도 및 적용 요법
BR112015029214A2 (pt) 2013-05-23 2017-07-25 Bayer Pharma AG composição farmacêutica, seu uso e regime de aplicação dessa composição farmacêutica para contracepção conforme a necessidade
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
ES2877186T3 (es) 2015-06-18 2021-11-16 Estetra Sprl Comprimido orodispersable que contiene estetrol
TN2017000499A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
GEP20217243B (en) 2015-06-18 2021-04-26 Sprl Estetra Orodispersible dosage unit containing an estetrol component
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception

Also Published As

Publication number Publication date
ZA200404114B (en) 2005-10-26
HUP0105173A2 (hu) 2003-08-28
BR0210595A (pt) 2004-06-08
AP2004003046A0 (en) 2004-06-30
DE60203929D1 (de) 2005-06-02
HRP20040584B1 (en) 2012-11-30
GEP20063882B (en) 2006-07-25
AP1849A (en) 2008-05-23
HU227198B1 (en) 2010-10-28
JP2005516904A (ja) 2005-06-09
DK1448207T3 (da) 2005-06-27
EA006545B1 (ru) 2006-02-24
ES2239727T3 (es) 2005-10-01
NO20041607L (no) 2004-04-20
IS2691B (is) 2010-10-15
MA27076A1 (fr) 2004-12-20
CA2450359C (en) 2011-05-10
HUP0105173A3 (en) 2004-03-29
CA2450359A1 (en) 2003-06-05
ECSP045171A (es) 2004-08-27
HUP0105173D0 (en) 2002-02-28
US20050288264A2 (en) 2005-12-29
EP1448207A1 (en) 2004-08-25
TNSN04048A1 (en) 2006-06-01
CN1551774A (zh) 2004-12-01
PL369520A1 (en) 2005-04-18
NO333984B1 (no) 2013-11-04
RS4204A (en) 2007-02-05
US20050032755A1 (en) 2005-02-10
PT1448207E (pt) 2005-08-31
IS7065A (is) 2003-12-05
KR20040066088A (ko) 2004-07-23
PL206010B1 (pl) 2010-06-30
EA200400731A1 (ru) 2004-12-30
SI1448207T1 (en) 2005-10-31
DE60203929T2 (de) 2006-01-19
OA12730A (fr) 2006-06-28
RS50768B (sr) 2010-08-31
NZ530056A (en) 2005-02-25
ATE293978T1 (de) 2005-05-15
KR100908161B1 (ko) 2009-07-16
HRP20040584A2 (en) 2005-02-28
IL159394A0 (en) 2004-06-01
UA79942C2 (en) 2007-08-10
AU2002347401A1 (en) 2003-06-10
WO2003045397A1 (en) 2003-06-05
EP1448207B1 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
JP2005516904A5 (es)
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
MY129281A (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of a acute condition of asthma
EA200400664A1 (ru) Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii
BG105173A (en) Novel salt form of pantoprazole
SE9901573D0 (sv) New compounds
TW200503775A (en) Pharmaceutical composition and method for treating
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
OA12806A (en) Novel perindopril salt and pharmaceutical compositions containing same.
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
TWI264311B (en) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
HUP0101622A2 (hu) Abacavir, lamivudin és zidovudin tartalmú homogén gyógyászati készítmények
AR046226A1 (es) Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
BE2016C017I2 (es)
SE9901572D0 (sv) New compounds
BR0207297A (pt) Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
US3197370A (en) Pyrilamine tannate compositions
MXPA02006034A (es) Formas de dosis mucosaloral de apomorfina.
TW200640468A (en) Pharmaceutical product for oral contraception
US3567828A (en) Organic compounds
KR920700626A (ko) 톡소플라스마병의 치료용 약제

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status